(Q54551498)

English

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

chronic myeloid leukemia

0 references

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

David Marin

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Amr R Ibrahim

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Claire Lucas

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Lihui Wang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Richard E Clark

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jane F Apperley

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Dragana Milojkovic

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Marco Bua

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jiri Pavlu

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Christos Paliompeis

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Alistair Reid

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Katayoun Rezvani

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

John M Goldman

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Letizia Foroni

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

0 references

publication date

7 November 2011

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

30

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

232-238

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic and molecular monitoring of residual disease in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of imatinib as frontline therapy for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of accelerated disease in chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/22067393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2011.38.6565

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22067393%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54551498&oldid=1411263322"